A Search Service for Abbreviation / Long Form

■ 略語/展開語 : NS/nanosponges

合計出現文献数: 23
/ ページ
略語:   NS  (>> 共起略語)
展開形:   nanosponges
No. 発表年 題目 共起略語
2021 Cyclodextrin Nanosponges Inclusion Compounds Associated with Gold Nanoparticles for Potential Application in the Photothermal Release of Melphalan and Cytoxan. Cyt, EDS, IC, MPH, SEM, TGA, XRPD
2021 Formulation and in vitro evaluation of topical nanosponge-based gel containing butenafine for the treatment of fungal skin infection. BTF, DL, EC, EE, PDI, PS, PVA, ZP
2021 Nanosponge Approach -A Plethora of Opportunities as a Promising Nanocarrier for Novel Drug Delivery. ---
2021 Preparation, Characterization, and Pharmacological Investigation of Withaferin-A Loaded Nanosponges for Cancer Therapy; In Vitro, In Vivo and Molecular Docking Studies. DSC, EC, FTIR, PDI, SEM, WF-A
2021 Structural Adaptive, Self-Separating Material for Removing Ibuprofen from Waters and Sewage. BET, BJH, DSC, EA, FTIR, IBU, SEM, TGA
2020 Cascade reaction engineering on zirconia-supported mesoporous MFI zeolites with tunable Lewis-Brønsted acid sites: a case of the one-pot conversion of furfural to γ-valerolactone. GVL
2020 Cross-Linked Pillar[6]arene Nanosponges Fabricated by the Use of a Supra-Amphiphilic Template: Cargo Encapsulation and Overcoming Multidrug Resistance. MDR
2020 Degree of crosslinking in beta-cyclodextrin-based nanosponges and their effect on piperine encapsulation. PIP
2020 Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. beta-CD, CFN, CUR, DMC
10  2020 Understanding Surface Interaction and Inclusion Complexes between Piroxicam and Native or Crosslinked beta-Cyclodextrins: The Role of Drug Concentration. CDs
11  2018 alpha-Cyclodextrin and alpha-Cyclodextrin Polymers as Oxygen Nanocarriers to Limit Hypoxia/Reoxygenation Injury: Implications from an In Vitro Model. alpha-CD, alpha-CD NS, alpha-CD POLY, HF, I/R, MI
12  2018 Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid. DMC, EA, EA-NS
13  2018 Encapsulation of Babchi Oil in Cyclodextrin-Based Nanosponges: Physicochemical Characterization, Photodegradation, and In Vitro Cytotoxicity Studies. BO
14  2018 In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium. AC, AC-NS, beta-CD
15  2017 Extended release delivery of erlotinib glutathione nanosponge for targeting lung cancer. ETB, ETB-NS
16  2016 Guest-matrix interactions affect the solvation of cyclodextrin-based polymeric hydrogels: a UV Raman scattering study. CAF
17  2015 Acute and repeated dose toxicity studies of different beta-cyclodextrin-based nanosponge formulations. ---
18  2015 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure. AC-NS, IOP, RGC
19  2013 Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy. Carb-NS
20  2013 Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment. DEX
21  2012 Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances. ---
22  2011 Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. XRPD
23  2009 Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. CAM